Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Terahertz-Driven Stark Spectroscopy of CdSe and CdSe-CdS Core-Shell Quantum Dots.

Pein BC, Lee CK, Shi L, Shi J, Chang W, Hwang HY, Scherer J, Coropceanu I, Zhao X, Zhang X, Bulović V, Bawendi MG, Willard AP, Nelson KA.

Nano Lett. 2019 Nov 13;19(11):8125-8131. doi: 10.1021/acs.nanolett.9b03342. Epub 2019 Oct 24.

PMID:
31635457
2.

Survey on structural preparedness for treatment of thoracic and abdominal trauma in German-speaking level 1 trauma centers.

Scherer J, Sprengel K, Simmen HP, Pape HC, Osterhoff G.

Eur J Trauma Emerg Surg. 2019 Aug 31. doi: 10.1007/s00068-019-01218-x. [Epub ahead of print]

PMID:
31473771
3.

Testing the influence of musical expertise on novel word learning across the lifespan using a cross-sectional approach in children, young adults and older adults.

Dittinger E, Scherer J, Jäncke L, Besson M, Elmer S.

Brain Lang. 2019 Nov;198:104678. doi: 10.1016/j.bandl.2019.104678. Epub 2019 Aug 23.

PMID:
31450024
4.

A Descriptive Analysis of an Ambulatory Kidney Palliative Care Program.

Scherer JS, Harwood K, Frydman JL, Moriyama D, Brody AA, Modersitzki F, Blaum CS, Chodosh J.

J Palliat Med. 2019 Jul 11. doi: 10.1089/jpm.2018.0647. [Epub ahead of print]

PMID:
31295050
5.

[Computer-assisted decision-making for trauma patients].

Osterhoff G, Pförringer D, Scherer J, Juhra C, Maerdian S, Back DA; Arbeitsgruppe Digitalisierung der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie.

Unfallchirurg. 2019 Jun 3. doi: 10.1007/s00113-019-0676-y. [Epub ahead of print] German.

PMID:
31161286
6.

Re-traumatization Cycle: Sexual Abuse, Post-Traumatic Stress Disorder and Sexual Risk Behaviors among Club Drug Users.

Narvaez JCM, Remy L, Bermudez MB, Scherer JN, Ornell F, Surratt H, Kurtz SP, Pechansky F.

Subst Use Misuse. 2019;54(9):1499-1508. doi: 10.1080/10826084.2019.1589521. Epub 2019 Apr 25.

PMID:
31020892
7.

User experience and operational feasibility of four point-of-collection oral fluid drug-testing devices according to Brazilian traffic agents.

Pechansky F, Scherer JN, Schuch JB, Roglio V, Telles YM, Silvestrin R, Pasa G, Sousa T.

Traffic Inj Prev. 2019;20(1):30-36. doi: 10.1080/15389588.2018.1537486. Epub 2019 Mar 1.

PMID:
30822144
8.

The Cambia Sojourns Scholars Leadership Program: Projects and Reflections on Leadership in Palliative Care.

Dahlin C, Sanders J, Calton B, DeSanto-Madeya S, Donesky D, Lakin JR, Roeland E, Scherer JS, Walling A, Williams B.

J Palliat Med. 2019 Jul;22(7):823-829. doi: 10.1089/jpm.2018.0523. Epub 2019 Feb 27.

PMID:
30810459
9.

A Conceptual Framework of Palliative Care across the Continuum of Advanced Kidney Disease.

Lam DY, Scherer JS, Brown M, Grubbs V, Schell JO.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):635-641. doi: 10.2215/CJN.09330818. Epub 2019 Feb 6.

PMID:
30728167
10.

Clinical and Toxicological Profile of NBOMes: A Systematic Review.

Marchi NC, Scherer JN, Fara LS, Remy L, Ornel R, Reis M, Zamboni A, Paim M, Fiorentin TR, Wayhs CAY, Von Diemen L, Pechansky F, Kessler FHP, Limberger RP.

Psychosomatics. 2019 Mar - Apr;60(2):129-138. doi: 10.1016/j.psym.2018.11.002. Epub 2018 Nov 13. Review.

PMID:
30606495
11.

Predictive factors associated with driving under the influence among Brazilian drug-using drivers.

Scherer JN, Silvello D, Volpato VL, Roglio VS, Fara L, Ornell F, von Diemen L, Kessler FP, Pechansky F.

Accid Anal Prev. 2019 Feb;123:256-262. doi: 10.1016/j.aap.2018.12.003. Epub 2018 Dec 13.

PMID:
30553128
12.

Brain-derived neurotrophic factor in substance use disorders: A systematic review and meta-analysis.

Ornell F, Hansen F, Schuch FB, Pezzini Rebelatto F, Tavares AL, Scherer JN, Valerio AG, Pechansky F, Paim Kessler FH, von Diemen L.

Drug Alcohol Depend. 2018 Dec 1;193:91-103. doi: 10.1016/j.drugalcdep.2018.08.036. Epub 2018 Oct 12.

PMID:
30347311
13.

A snapshot of anatomy teaching: Peer-led anatomy boot camps - Priming for success?

Scherer JJ, Reichrath S, Tschernig T, Maxeiner S.

Ann Anat. 2019 Jan;221:141-147. doi: 10.1016/j.aanat.2018.10.005. Epub 2018 Oct 13.

PMID:
30326262
14.

Subcutaneous internal anterior fixation of pelvis fractures-which configuration of the InFix is clinically optimal?-a retrospective study.

Scherer J, Tiziani S, Sprengel K, Pape HC, Osterhoff G.

Int Orthop. 2019 Sep;43(9):2161-2166. doi: 10.1007/s00264-018-4110-9. Epub 2018 Sep 8.

PMID:
30196442
15.

Markers for Severity of Problems in Interpersonal Relationships of Crack Cocaine Users from a Brazilian Multicenter Study.

Pachado MP, Scherer JN, Guimarães LSP, von Diemen L, Pechansky F, Kessler FHP, de Almeida RMM.

Psychiatr Q. 2018 Dec;89(4):923-936. doi: 10.1007/s11126-018-9590-7.

PMID:
30019298
16.

Role of kinesins in directed adenovirus transport and cytoplasmic exploration.

Zhou J, Scherer J, Yi J, Vallee RB.

PLoS Pathog. 2018 May 21;14(5):e1007055. doi: 10.1371/journal.ppat.1007055. eCollection 2018 May.

17.

Ten Tips Nephrologists Wish the Palliative Care Team Knew About Caring for Patients with Kidney Disease.

Bansal AD, Leonberg-Yoo A, Schell JO, Scherer JS, Jones CA.

J Palliat Med. 2018 Apr;21(4):546-551. doi: 10.1089/jpm.2018.0087.

PMID:
29596042
18.

Active Brazilian crack cocaine users: nutritional, anthropometric, and drug use profiles.

Escobar M, Scherer JN, Soares CM, Guimarães LSP, Hagen ME, von Diemen L, Pechansky F.

Braz J Psychiatry. 2018 Oct-Dec;40(4):354-360. doi: 10.1590/1516-4446-2017-2409. Epub 2018 Feb 15.

19.

Leptin levels and its correlation with crack-cocaine use severity: A preliminary study.

Escobar M, Scherer JN, Ornell F, Bristot G, Soares CM, Guimarães LSP, Von Diemen L, Pechansky F.

Neurosci Lett. 2018 Apr 3;671:56-59. doi: 10.1016/j.neulet.2018.02.009. Epub 2018 Feb 5.

PMID:
29421542
20.

Metal selectivity determinants in a family of transition metal transporters.

Podar D, Scherer J, Noordally Z, Herzyk P, Nies D, Sanders D.

J Biol Chem. 2018 Jan 5;293(1):402. doi: 10.1074/jbc.AAC117.001146. No abstract available.

21.

Hepatitis C: clinical and biological features related to different forms of cocaine use.

Schuch-Goi SB, Scherer JN, Kessler FHP, Sordi AO, Pechansky F, von Diemen L.

Trends Psychiatry Psychother. 2017 Oct-Dec;39(4):285-292. doi: 10.1590/2237-6089-2016-0076. Review.

22.

Anxiety and depression symptoms in Brazilian sexual minority ecstasy and LSD users.

Remy LS, Scherer J, Guimarães L, Surratt HL, Kurtz SP, Pechansky F, Kessler F.

Trends Psychiatry Psychother. 2017 Oct-Dec;39(4):239-246. doi: 10.1590/2237-6089-2016-0081. Epub 2017 Nov 13.

23.

Comparison of Cocaine/Crack Biomarkers Concentrations in Oral Fluid, Urine and Plasma Simultaneously Collected From Drug Users.

Fiorentin TR, Scherer JN, Marcelo MCA, Sousa TRV, Pechansky F, Ferrão MF, Limberger RP.

J Anal Toxicol. 2018 Mar 1;42(2):69-76. doi: 10.1093/jat/bkx085.

PMID:
29140478
24.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers.

Monteith D, Collins EC, Vandermeulen C, Van Hecken A, Raddad E, Scherer JC, Grayzel D, Schuetz TJ, de Hoon J.

Front Pharmacol. 2017 Oct 17;8:740. doi: 10.3389/fphar.2017.00740. eCollection 2017.

25.

Functional Carboxy-Terminal Fluorescent Protein Fusion to Pseudorabies Virus Small Capsid Protein VP26.

Hogue IB, Jean J, Esteves AD, Tanneti NS, Scherer J, Enquist LW.

J Virol. 2017 Dec 14;92(1). pii: e01193-17. doi: 10.1128/JVI.01193-17. Print 2018 Jan 1.

26.

Crack-cocaine users have less family cohesion than alcohol users.

Marchi NC, Scherer JN, Pachado MP, Guimarães LS, Siegmund G, de Castro MN, Halpern S, Benzano D, Formigoni ML, Cruz M, Pechansky F, Kessler FH.

Braz J Psychiatry. 2017 Oct-Dec;39(4):346-351. doi: 10.1590/1516-4446-2016-2091. Epub 2017 Aug 30.

27.

Guide wire insertion for percutaneous LC2 screws in acetabular and pelvic ring fixation using a transpedicular working cannula.

Scherer J, Guy P, Lefaivre KA, Pape HC, Werner CML, Osterhoff G.

Injury. 2017 Oct;48(10):2360-2364. doi: 10.1016/j.injury.2017.08.049. Epub 2017 Aug 25.

28.

Anterior subcutaneous internal fixation of the pelvis - what rod-to-bone distance is anatomically optimal?

Osterhoff G, Aichner EV, Scherer J, Simmen HP, Werner CML, Feigl GC.

Injury. 2017 Oct;48(10):2162-2168. doi: 10.1016/j.injury.2017.08.047. Epub 2017 Aug 25.

29.

Building an Outpatient Kidney Palliative Care Clinical Program.

Scherer JS, Wright R, Blaum CS, Wall SP.

J Pain Symptom Manage. 2018 Jan;55(1):108-116.e2. doi: 10.1016/j.jpainsymman.2017.08.005. Epub 2017 Aug 10. Erratum in: J Pain Symptom Manage. 2018 Mar;55(3):e12.

PMID:
28803081
30.

Terahertz-Driven Luminescence and Colossal Stark Effect in CdSe-CdS Colloidal Quantum Dots.

Pein BC, Chang W, Hwang HY, Scherer J, Coropceanu I, Zhao X, Zhang X, Bulović V, Bawendi M, Nelson KA.

Nano Lett. 2017 Sep 13;17(9):5375-5380. doi: 10.1021/acs.nanolett.7b01837. Epub 2017 Aug 23.

PMID:
28786683
31.

[Clinical and social vulnerabilities in crack users according to housing status: a multicenter study in six Brazilian state capitals].

Halpern SC, Scherer JN, Roglio V, Faller S, Sordi A, Ornell F, Dalbosco C, Pechansky F, Kessler F, Diemen LV.

Cad Saude Publica. 2017 Jul 3;33(6):e00037517. doi: 10.1590/0102-311X00037517. Portuguese.

32.

Treatment decisions for older adults with advanced chronic kidney disease.

Rosansky SJ, Schell J, Shega J, Scherer J, Jacobs L, Couchoud C, Crews D, McNabney M.

BMC Nephrol. 2017 Jun 19;18(1):200. doi: 10.1186/s12882-017-0617-3. Review.

33.

Reliability of point-of-collection testing devices for drugs of abuse in oral fluid: A systematic review and meta-analysis.

Scherer JN, Fiorentin TR, Borille BT, Pasa G, Sousa TRV, von Diemen L, Limberger RP, Pechansky F.

J Pharm Biomed Anal. 2017 Sep 5;143:77-85. doi: 10.1016/j.jpba.2017.05.021. Epub 2017 May 13. Review.

PMID:
28577420
34.

Simultaneous determination of cocaine/crack and its metabolites in oral fluid, urine and plasma by liquid chromatography-mass spectrometry and its application in drug users.

Fiorentin TR, D'Avila FB, Comiran E, Zamboni A, Scherer JN, Pechansky F, Borges PEM, Fröehlich PE, Limberger RP.

J Pharmacol Toxicol Methods. 2017 Jul;86:60-66. doi: 10.1016/j.vascn.2017.04.003. Epub 2017 Apr 7.

PMID:
28395991
35.

Oral Fluid Testing for Cocaine: Analytical Evaluation of Two Point-of-Collection Drug Screening Devices.

Scherer JN, Fiorentin TR, Sousa TRV, Limberger RP, Pechansky F.

J Anal Toxicol. 2017 Jun 1;41(5):392-398. doi: 10.1093/jat/bkx018.

PMID:
28334841
36.

Factors Affecting Functional Impairment among Elderly Germans - Results of a Longitudinal Study.

Hajek A, Luck T, Brettschneider C, Posselt T, Lange C, Wiese B, Steinmann S, Weyerer S, Werle J, Pentzek M, Fuchs A, Stein J, Bickel H, Mösch E, Wagner M, Heser K, Maier W, Scherer JM, Riedel-Heller SG, König HH.

J Nutr Health Aging. 2017;21(3):299-306. doi: 10.1007/s12603-016-0771-5.

PMID:
28244570
37.

Illness Trajectories: Description and Clinical Use #326.

Comstock Barker P, Scherer JS.

J Palliat Med. 2017 Apr;20(4):426-427. doi: 10.1089/jpm.2016.0554. Epub 2017 Feb 2. No abstract available.

PMID:
28151051
38.

Neuromuscular responses of the plantar flexors to whole-body vibration.

Harwood B, Scherer J, Brown RE, Cornett KMD, Kenno KA, Jakobi JM.

Scand J Med Sci Sports. 2017 Dec;27(12):1569-1575. doi: 10.1111/sms.12803. Epub 2016 Dec 29.

PMID:
28033657
39.

Erratum to "Prevalence of driving under the influence of psychoactive substances and road traffic crashes among Brazilian crack-using drivers" [Drug Alcohol Depend. 168 (2016) 255-262].

Scherer JN, Silvestrin R, Ornell F, Roglio V, Sousa TR; Brazilian Crack Group, Von Diemen L, Kessler FH, Pechansky F.

Drug Alcohol Depend. 2017 Feb 1;171:e227. doi: 10.1016/j.drugalcdep.2016.11.004. Epub 2016 Dec 21. No abstract available.

PMID:
28012714
40.

Prevalence of driving under the influence of psychoactive substances and road traffic crashes among Brazilian crack-using drivers.

Scherer JN, Silvestrin R, Ornell F, Roglio V, Sousa TRV; Brazilian Crack Group, Von Diemen L, Kessler FHP, Pechansky F.

Drug Alcohol Depend. 2016 Nov 1;168:255-262. doi: 10.1016/j.drugalcdep.2016.09.017. Epub 2016 Oct 1. Erratum in: Drug Alcohol Depend. 2017 Feb 1;171:e227.

PMID:
27736679
41.

Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients.

Scherer JS, Combs SA, Brennan F.

Am J Kidney Dis. 2017 Jan;69(1):117-128. doi: 10.1053/j.ajkd.2016.07.031. Epub 2016 Sep 29. Review.

42.

Practice Change Is Needed for Dialysis Decision Making with Older Adults with Advanced Kidney Disease.

Scherer JS, Moss AH.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1732-1734. doi: 10.2215/CJN.08770816. Epub 2016 Sep 22. No abstract available.

43.

Dual-Color Herpesvirus Capsids Discriminate Inoculum from Progeny and Reveal Axonal Transport Dynamics.

Scherer J, Yaffe ZA, Vershinin M, Enquist LW.

J Virol. 2016 Oct 14;90(21):9997-10006. doi: 10.1128/JVI.01122-16. Print 2016 Nov 1.

44.

Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.

Berger KL, Sarrazin C, Nelson DR, Scherer J, Sha N, Marquis M, Côté-Martin A, Vinisko R, Stern JO, Mensa FJ, Kukolj G.

PLoS One. 2016 Aug 5;11(8):e0160668. doi: 10.1371/journal.pone.0160668. eCollection 2016.

45.

High levels of brain-derived neurotrophic factor are associated with treatment adherence among crack-cocaine users.

Scherer JN, Schuch S, Ornell F, Sordi AO, Bristot G, Pfaffenseller B, Kapczinski F, Kessler FHP, Fumagalli F, Pechansky F, von Diemen L.

Neurosci Lett. 2016 Sep 6;630:169-175. doi: 10.1016/j.neulet.2016.07.050. Epub 2016 Jul 26.

PMID:
27473943
46.

Exocytosis of Alphaherpesvirus Virions, Light Particles, and Glycoproteins Uses Constitutive Secretory Mechanisms.

Hogue IB, Scherer J, Enquist LW.

MBio. 2016 Jun 7;7(3). pii: e00820-16. doi: 10.1128/mBio.00820-16.

47.

Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection.

Nishiguchi S, Urano Y, Suzaki K, Taniguchi A, Scherer J, Berger KL, Quinson AM, Stern JO, Omata M.

Hepatol Res. 2017 Mar;47(3):E142-E151. doi: 10.1111/hepr.12741. Epub 2016 Aug 10.

PMID:
27153246
48.

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.

Jensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourlière M, Hassanein T, Nishiguchi S, Kao JH, Omata M, Paik SW, Wong DK, Tam E, Kaita K, Feinman SV, Stern JO, Scherer J, Quinson AM, Voss F, Gallivan JP, Böcher WO, Ferenci P.

Ann Hepatol. 2016 May-Jun;15(3):333-49. doi: 10.5604/16652681.1198803.

49.

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.

Cooper DA, Cordery DV, Zajdenverg R, Ruxrungtham K, Arastéh K, Bergmann F, Neto JL, Scherer J, Chaves RL, Robinson P; study team.

PLoS One. 2016 Jan 5;11(1):e0144917. doi: 10.1371/journal.pone.0144917. eCollection 2016.

50.

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.

Jensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourlière M, Hassanein T, Nishiguchi S, Kao JH, Omata M, Paik SW, Wong DK, Tam E, Kaita K, Feinman SV, Stern JO, Scherer J, Quinson AM, Voss F, Gallivan JP, Böcher WO, Ferenci P.

Ann Hepatol. 2016 May - Jun;15(3):333-349. doi: 10.5604/16652681.1198803.

Supplemental Content

Loading ...
Support Center